Subclinical Cardiotoxicity: The Emerging Role of Myocardial Work and Other Imaging Techniques

Taylor, 2012, Heart disease and cancer: the new discipline of cardioncology, Ear Heart J, 33, 151 Biasillo, 2017, Cardio-oncology: gaps in knowledge, goals, advances, and educational efforts, Curr Oncol Rep, 19, 55, 10.1007/s11912-017-0610-9 Zamorano, 2016, 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for Cancer Treatments and Cardiovascular Toxicity of the European Society of Cardiology, Eur Heart J, 37, 2768, 10.1093/eurheartj/ehw211 Habibian, 2019, Monitoring the heart during cancer therapy, Eur Heart J Suppl, 21, M44, 10.1093/eurheartj/suz230 Ewer, 2015, Cardiotoxicity of anticancer treatments, Nat Rev Cardiol, 12, 620, 10.1038/nrcardio.2015.133 Plana, 2014, Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, J Am Soc Echocardiogr, 27, 911, 10.1016/j.echo.2014.07.012 Cardinale, 2017, Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy, Expert Rev Mol Diagn, 17, 245, 10.1080/14737159.2017.1283219 Celutkiene, 2018, Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology, Eur J Heart Fail, 20, 1615, 10.1002/ejhf.1330 Čelutkienė, 2020, Eur J Heart Fail, 22, 1504, 10.1002/ejhf.1957 Curigliano, 2020, Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations, Ann Oncol, 31, 171, 10.1016/j.annonc.2019.10.023 Alexandre, 2020, Cardiovascular toxicity related to cancer treatment: a pragmatic approach to the American and European Cardio-Oncology Guidelines, J Am Heart Assoc, 9, 10.1161/JAHA.120.018403 Di Lisi, 2011, Chemotherapy-induced cardiotoxicity: role of the tissue Doppler in the early diagnosis of left ventricular dysfunction, Anticancer Drugs, 22, 468, 10.1097/CAD.0b013e3283443704 Voigt, 2015, Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging, Eur Heart J Cardiovasc Imaging, 16, 1, 10.1093/ehjci/jeu184 McGregor, 2020, Role of myocardial strain imaging in surveillance and management of cancer therapeutics-related cardiac dysfunction: A systematic review, Echocardiography Thavendiranathan, 2014, Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review, J Am Coll Cardiol, 63, 2751, 10.1016/j.jacc.2014.01.073 Kalam, 2014, Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction, Heart, 100, 1673, 10.1136/heartjnl-2014-305538 Ali, 2016, Myocardial strain is associated with adverse clinical cardiac events in patients treated with anthracyclines, J Am Soc Echocardiogr, 29, 522, 10.1016/j.echo.2016.02.018 Negishi, 2013, Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity, J Am Soc Echocardiogr, 26, 493, 10.1016/j.echo.2013.02.008 Santoro, 2019, Strain-oriented strategy for guiding cardioprotection initiation of breast cancer patients experiencing cardiac dysfunction, Eur Heart J Cardiovasc Imaging, 20, 1345, 10.1093/ehjci/jez194 Negishi, 2018, Rationale and design of the strain surveillance of chemotherapy for improving cardiovascular outcomes: the SUCCOUR trial, JACC Cardiovasc Imaging, 11, 1098, 10.1016/j.jcmg.2018.03.019 Cardinale, 2000, Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy, J Am Coll Cardiol, 36, 517, 10.1016/S0735-1097(00)00748-8 Cardinale, 2004, Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy, Circulation, 109, 2749, 10.1161/01.CIR.0000130926.51766.CC Clerico, 2020, High-sensitivity cardiac troponin I and T methods for the early detection of myocardial injury in patients on chemotherapy, Clin Chem Lab Med Sawaya, 2012, Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with an- thracyclines, taxanes, and trastuzumab, Circ Cardiovasc Imaging, 5, 596, 10.1161/CIRCIMAGING.112.973321 Tan, 2018, Role of biomarkers in prediction of cardiotoxicity during cancer treatment, Curr Treat Options Cardiovasc Med, 20, 55, 10.1007/s11936-018-0641-z Pudil, 2020, Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology, Eur J Heart Fail, 22, 1966, 10.1002/ejhf.2017 Ponikowski, 2016, Eur Heart J, 37, 2129, 10.1093/eurheartj/ehw128 Feola, 2011, Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide, Int J Cardiol, 148, 194, 10.1016/j.ijcard.2009.09.564 Skovgaard, 2014, BNP predicts chemotherapy-related cardiotoxicity and death: comparison with gated equilibrium radionuclide ventriculography, PLoS One, 9, e96736, 10.1371/journal.pone.0096736 De Iuliis, 2016, Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients, Tumour Biol, 37, 3379, 10.1007/s13277-015-4183-7 Michel, 2020, Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis, Eur J Heart Fail, 22, 350, 10.1002/ejhf.1631 Ky, 2014, Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab, J Am Coll Cardiol, 63, 809, 10.1016/j.jacc.2013.10.061 Manganaro, 2019, Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study, Eur Heart J Cardiovasc Imaging, 20, 582, 10.1093/ehjci/jey188 Delhaas, 1994, Regional fibre stress-fibre strain area as an estimate of regional blood flow and oxygen demand in the canine heart, J Physiol, 477, 481, 10.1113/jphysiol.1994.sp020209 Russell, 2012, A novel clinical method for quantification of regional left ventricular pressurestrain loop area: a non-invasive index of myocardial work, Eur Heart J, 33, 724, 10.1093/eurheartj/ehs016 Hubert, 2018, Estimation of myocardial work from pressure-strain loops analysis: an experimental evaluation, Eur Heart J Cardiovasc Imaging, 19, 1372, 10.1093/ehjci/jey024 Manganaro, 2020, Correlation between non-invasive myocardial work indices and main parameters of systolic and diastolic function: results from the EACVI NORRE study, Eur Heart J Cardiovasc Imaging, 21, 533, 10.1093/ehjci/jez203 Hiemstra, 2020, Myocardial Work in Non obstructive Hypertrophic Cardiomyopathy: Implications for Outcome, J Am Soc Echocardiogr, 33, 1201, 10.1016/j.echo.2020.05.010 Boe, 2015, Non-invasive myocardial work index identifies acute coronary occlusion in patients with nonST-segment elevation-acute coronary syndrome, Eur Heart J Cardiovasc Imaging, 16, 1247, 10.1093/ehjci/jev078 Galli, 2018, Value of myocardial work estimation in the prediction of response to cardiac resynchronization therapy, J Am Soc Echocardiogr, 31, 220, 10.1016/j.echo.2017.10.009 Spinelli, 2020, Does left ventricular function predict cardiac outcome in Anderson-Fabry disease?, Int J Cardiovasc Imaging Triantafyllou, 2020, Myocardial work analysis in screening of familial dilated cardiomyopathy, Eur Heart J, 41, 10.1093/ehjci/ehaa946.0092 Novo, 2020, Usefulness of Stress Echocardiography in the Management of Patients Treated with Anticancer Drugs, J Am Soc Echocardiogr, 19 Civelli, 2006, Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy- induced cardiac toxicity, Int J Cardiol, 111, 120, 10.1016/j.ijcard.2005.07.029 Plana, 2018, Multi-Modality Imaging in the Assessment of Cardiovascular Toxicity in the Cancer Patient, JACC Cardiovasc Imaging, 11, 1173, 10.1016/j.jcmg.2018.06.003 Grover, 2013, Left and right ventricular effects of anthracycline and trastuzumab chemotherapy: a prospective study using novel cardiac imaging and biochemical markers, Int J Cardiol, 168, 5465, 10.1016/j.ijcard.2013.07.246 Galan-Arriola, 2019, Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity, J Am Coll Cardiol, 73, 779, 10.1016/j.jacc.2018.11.046 Burrage, 2020, The use of cardiovascular magnetic resonance as an early non-invasive biomarker for cardiotoxicity in cardio-oncology, Cardiovasc Diagn Ther, 10, 610, 10.21037/cdt-20-165